---
title: CDMO Daily News — September 30, 2026
slug: daily-news-2026-09-30-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: September 30 CDMO daily: Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline — Quotient Sciences' AI formulation…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-09-30-cdmo
published_at: 2026-09-30T00:00:56.004Z
last_updated: 2026-09-30T00:01:39.948Z
---

### [Quotient Sciences](/companies/quotientsciences) Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline
- [Quotient Sciences](/companies/quotientsciences) will apply machine learning and Bayesian optimization to accelerate oral formulation development for Acesion Pharma's early-stage small-molecule atrial fibrillation candidates.
- The AI-enhanced solution integrates within Quotient's Translational Pharmaceutics® platform to predict formulation performance earlier and shorten development timelines.

**Operational Impact**

[Quotient Sciences](/companies/quotientsciences)' AI formulation platform demonstrates differentiated early-stage drug-product development capability that may strengthen its competitive position in translational pharmaceutics and attract biotech partners seeking faster formulation-to-clinic timelines.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/quotient-sciences-and-acesion-pharma-launch-ai-formulation-collaboration)*

## References

1. [PharmaSource RSS — Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline](https://pharmasource.global/content/news/cdmo-news/quotient-sciences-and-acesion-pharma-launch-ai-formulation-collaboration)

Source: https://www.cdmo.directory/posts/daily-news-2026-09-30-cdmo